Humana AB has resolved to repurchase own shares

Under the authorisation from the annual general meeting 2025, the board of Humana AB has resolved to repurchase no more than 1,500,000 own shares for the purpose of enabling the improvement of the company’s capital structure and to increase the flexibility for the board in connection with potential future corporate acquisitions

Any repurchase will be made on Nasdaq Stockholm in accordance with the Nordic Main Market Rulebook for Issuers of Shares and take place before the annual general meeting 2026. Own shares may be repurchased to the extent the company’s holdings of own shares in total amounts to no more than ten per cent of the total number of shares in the company.

The shares will be repurchased in cash and at a price within the stock market price interval registered at any given time, such interval being the interval between the highest purchase price and the lowest sales price. 

For information on the implementation of the share repurchases, please see www.nasdaq.com. Repurchase of shares will not be press released separately, unless mandatory disclosure obligations apply.

The total number of shares in the company amounts to 51,826,058, of which the company at the time of this press release holds 1,985,273 own shares.

For more information, please contact:

Christoffer Herou, CFO, +46 72 582 86 16, [email protected]

Ewelina Pettersson, Head of IR, +46 73 074 79 12, [email protected]